MACC1 and colorectal carcinoma: Data revealed that worse survival had been observed for CRC patients with MACC1 above the cut-off than those with MACC1 below the cut-off (67.3 vs. 92.0 months; p < 0.001), and the 5-year SR for the two groups was 47.5 vs. 69.7% (p < 0.001; Supplementary Figure 1A).